These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2262 related items for PubMed ID: 9235072

  • 1. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H.
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.
    The Diabetes Prevention Program Research Group.
    Diabetes Care; 1999 Apr; 22(4):623-34. PubMed ID: 10189543
    [Abstract] [Full Text] [Related]

  • 4. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA.
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [Abstract] [Full Text] [Related]

  • 5. [Progress in the prevention of type 2 diabetes].
    Schernthaner G.
    Wien Klin Wochenschr; 2003 Nov 28; 115(21-22):745-57. PubMed ID: 14743578
    [Abstract] [Full Text] [Related]

  • 6. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
    Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M.
    Diabetes Care; 1998 Oct 28; 21(10):1720-5. PubMed ID: 9773737
    [Abstract] [Full Text] [Related]

  • 7. Prevention of type 2 diabetes in the prediabetic population.
    Maji D, Roy RU, Das S.
    J Indian Med Assoc; 2005 Nov 28; 103(11):609-11. PubMed ID: 16570766
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance.
    Uusitupa MI.
    Ann Med; 1996 Oct 28; 28(5):445-9. PubMed ID: 8949977
    [Abstract] [Full Text] [Related]

  • 10. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE, Diabetes Prevention Program Research Group.
    J Clin Endocrinol Metab; 2008 Dec 28; 93(12):4774-9. PubMed ID: 18826999
    [Abstract] [Full Text] [Related]

  • 11. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, Diabetes Prevention Program Research Group.
    Ann Intern Med; 2005 Mar 01; 142(5):323-32. PubMed ID: 15738451
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D.
    Drugs Today (Barc); 2013 Aug 01; 49(8):499-507. PubMed ID: 23977667
    [Abstract] [Full Text] [Related]

  • 13. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV.
    Diabetes Care; 1997 Apr 01; 20(4):537-44. PubMed ID: 9096977
    [Abstract] [Full Text] [Related]

  • 14. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B, Harris SB, Gerstein HC, Young TK, Raboud JM, Neuman J, Hanley AJ.
    Diabetes Obes Metab; 2006 Sep 01; 8(5):531-7. PubMed ID: 16918588
    [Abstract] [Full Text] [Related]

  • 15. Impaired glucose tolerance and impaired fasting glucose.
    Rao SS, Disraeli P, McGregor T.
    Am Fam Physician; 2004 Apr 15; 69(8):1961-8. PubMed ID: 15117017
    [Abstract] [Full Text] [Related]

  • 16. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A, Alos VA, Scanlan A, Maia CM, Davey A, Whitaker RC, Foster GD, Ackermann RT, O'Brien MJ.
    Contemp Clin Trials; 2015 Nov 15; 45(Pt B):320-327. PubMed ID: 26597415
    [Abstract] [Full Text] [Related]

  • 17. Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program.
    Diabetes Prevention Program Research Group.
    Diabetes Care; 2005 Jan 15; 28(1):138-44. PubMed ID: 15616247
    [Abstract] [Full Text] [Related]

  • 18. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ.
    Clin Ther; 2004 Feb 15; 26(2):304-21. PubMed ID: 15038953
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM, Schlessinger L, Kahn R.
    Ann Intern Med; 2005 Aug 16; 143(4):251-64. PubMed ID: 16103469
    [Abstract] [Full Text] [Related]

  • 20. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
    Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S.
    Diabet Med; 2015 Dec 16; 32(12):1611-6. PubMed ID: 25864699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 114.